Gastrectomy for stage IV gastric cancer. a systematic review and meta-analysis.

AIM Gastrectomy as a primary treatment for patients with metastatic gastric cancer (M1) is highly controversial. Herein, a review of the literature was undertaken with the aim of assessing evidence regarding associated morbidity and mortality, overall survival, palliation and quality of life. MATERIALS AND METHODS A systematic review of the literature from 1980 to 2013 was undertaken to identify relevant studies. Outcome data were pooled, and combined overall effect sizes were calculated using fixed or random effects models. The search identified 19 non-randomized studies reporting on 2,911 patients. RESULTS Overall postoperative mortality and morbidity were 14% and 27% and were higher in Western than in Asian patients. In studies published during the past decade postoperative mortality was less than 5%. The weighted 1- and 2-year overall survival rates were 38% and 17%, and were twice as high in Asian versus Western patients. In the meta-analysis, the 1-year overall survival was significantly higher in patients undergoing gastrectomy versus conservative (odds ratio (OR)=4.9, 95% confidence interval (CI)=3.2 to 7.5, p<0.0001) or gastrectomy versus non-resectional treatment (OR=2.6, 95% CI=1.7 to 4.3, p<0.0001). Studies reporting on quality of life and palliation indicate a possible benefit of such palliative gastrectomy. CONCLUSION A possible benefit of gastrectomy compared to non-resectional treatment for stage IV gastric cancer in terms of survival and palliation was evident but has to be cautiously interpreted due to potential sources of bias of retrospective non-randomized studies. Several questions regarding the optimal management of these patients remain unanswered and require a properly-designed randomized trial.

[1]  J. Louhimo,et al.  Does non‐curative gastrectomy improve survival in patients with metastatic gastric cancer? , 2012, Journal of surgical oncology.

[2]  M. Sierzega,et al.  Non-curative gastrectomy for metastatic gastric cancer: rationale and long-term outcome in multicenter settings. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[3]  A. Hernández-Guerrero,et al.  Self-expanding metal stents versus antrectomy for the palliative treatment of obstructive adenocarcinoma of the gastric antrum. , 2012, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[4]  K. Song,et al.  The Clinical Value of Non-curative Resection Followed by Chemotherapy for Incurable Gastric Cancer , 2012, World Journal of Surgery.

[5]  H. Scheuerlein,et al.  Non-curative gastric resection for patients with stage 4 gastric cancer—a single center experience and current review of literature , 2012, Langenbeck's Archives of Surgery.

[6]  W. Kim,et al.  The Value of Palliative Gastrectomy in Gastric Cancer with Distant Metastasis , 2012, Annals of Surgical Oncology.

[7]  J. Kładny,et al.  Advisability of palliative resections in incurable advanced gastric cancer. , 2011, Polski przeglad chirurgiczny.

[8]  M. Terashima,et al.  Influence of a Positive Proximal Margin on Oral Intake in Patients with Palliative Gastrectomy for Far Advanced Gastric Cancer , 2011, World Journal of Surgery.

[9]  K. Behrns Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial , 2011 .

[10]  Chun-yu Huang,et al.  Prognosis of 980 patients with gastric cancer after surgical resection. , 2010, Chinese journal of cancer.

[11]  S. Turanli The value of resection of primary tumor in gastric cancer patients with liver metastasis , 2010, The Indian journal of surgery.

[12]  J. Coebergh,et al.  Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. , 2010, European journal of cancer.

[13]  T. Kinoshitá,et al.  Predictive Factors Improving Survival After Gastrectomy in Gastric Cancer Patients with Peritoneal Carcinomatosis , 2010, World Journal of Surgery.

[14]  M. Yan,et al.  Survival Benefit of Non-curative Gastrectomy for Gastric Cancer Patients with Synchronous Distant Metastasis , 2010, Journal of Gastrointestinal Surgery.

[15]  T. Sohn,et al.  Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM. , 2009, Archives of surgery.

[16]  Y. Mok,et al.  Value of Nonpalliative Resection as a Therapeutic and Pre-Emptive Operation for Metastatic Gastric Cancer , 2009, World Journal of Surgery.

[17]  Y. Bang,et al.  Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. , 2008, Japanese journal of clinical oncology.

[18]  H. Shimada,et al.  Impact of palliative gastrectomy in patients with incurable advanced gastric cancer. , 2008, Anticancer research.

[19]  David Clark,et al.  The changing model of palliative care , 2008 .

[20]  Hong-fei Tong,et al.  Palliative gastrectomy and chemotherapy for stage IV gastric cancer , 2007, Journal of Cancer Research and Clinical Oncology.

[21]  R. Berman,et al.  Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups? , 2007, Journal of surgical oncology.

[22]  G. Mathew,et al.  PALLIATIVE GASTRECTOMY IN ADVANCED GASTRIC CANCER: IS IT WORTHWHILE? , 2006, ANZ journal of surgery.

[23]  N. Hanna,et al.  Is There a Role for Palliative Gastrectomy in Patients with Stage IV Gastric Cancer? , 2005, World Journal of Surgery.

[24]  B. Kremer,et al.  Palliation of Metastatic Gastric Cancer: Impact of Preoperative Symptoms and the Type of Operation on Survival and Quality of Life , 2004, World Journal of Surgery.

[25]  A. Seshimo,et al.  Prognostic factors in stage IV gastric cancer: univariate and multivariate analyses , 2000, Gastric Cancer.

[26]  A. Kakita,et al.  Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience. , 1998, Hepato-gastroenterology.

[27]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[28]  F. Branicki,et al.  Gastric carcinoma with synchronous liver metastases: palliative gastrectomy or not? , 1995, The Australian and New Zealand journal of surgery.

[29]  C. Roginski,et al.  Palliative surgery for gastric cancer , 1988, Cancer.

[30]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[31]  A. Yap,et al.  Surgical management of gastric carcinoma. Follow-up results in 465 consecutive cases. , 1982, American journal of surgery.